Programme by Day

Print this page

  Personalized Programme
The Personalized Programme enables you to compile an individual program with events and contributions of your interest. Therefore, it can be used very well to plan your actual congress visit at an early point of time. Please log on with your username and password to use the Personalized Programme.
» Login
» Create account
» Help

Thursday, 14 September 2017

next day »
No. S-01 - Symposium
Time: 09.30-11.00
Room: Plenary
Session title: Vocational rehabilitation in schizophrenia: a case of one-size-fits all or custom-tailoring? The Job Management program (JUMP) - nurturing the IPS concept
  June Ullevoldsśter Lystad, Oslo, Norway Chairperson
  Helen Bull, Oslo, Norway Co-Chairperson
No. S-02 - Symposium
Time: 09.30-11.00
Room: Harvard
Session title: How patients with schizophrenia remember and narrate personal life events? New insight on psychopathology and cognitive interventions related to autobiographical memory
  Fabrice Berna, Strasbourg, France Chairperson
  Christina Josefa Herold, Heidelberg, Germany Co-Chairperson
No. S-03 - Symposium
Time: 09.30-11.00
Room: Stanford
Session title: The natural course of movement disorders in long-stay psychiatric patients: the CuraÁao Extrapyramidal Syndromes study and the Dutch replication study
  P. Roberto Bakker, Amersfoort, Netherlands Chairperson
  Peter van Harten, Maastricht, Netherlands Co-Chairperson
No. S-04 - Symposium
Time: 09.30-11.00
Room: Princeton
Session title: Uncovering immune pathways in schizophrenia - a multidisciplinary approach
  Manuel Morrens, Antwerp, Belgium Chairperson
  Sophie Erhardt, Stockholm, Sweden Co-Chairperson
No. OC-01 - Opening Ceremony
Time: 11.30-12.15
Room: Plenary
Session title: Opening Ceremony
No. PL-01 - Plenary Lecture
Time: 12.15-13.00
Room: Plenary
Session title: Recovery - realistic goal or wishful thinking? A neuroscientists's view
  Wolfgang Gaebel, DŁsseldorf, Germany Chairperson
No. P-01 - Poster Session
Time: 13.30-14.30
Room: Foyer, Ground Floor
Session title: Diagnosis and epidemiology
  Frauke Schultze-Lutter, Bern, Switzerland Chairperson
No. P-02 - Poster Session
Time: 13.30-14.30
Room: Event Area, Ground Floor
Session title: Drug and alternative treatment 1
  Sonia Dollfus, Caen, France Chairperson
001 Effects of risperidone and olanzapine on indices of weight and fatty component of body composition of patients with schizophrenia  
  Elena Kornetova, Tomsk, Russia Speaker
003 Extrapyramidal side effects in elderly schizophrenic patients  
  Mihai Mutica, Bucharest, Romania Speaker
004 Association between serum glutamate and BDNF levels and response of schizophrenia patients to clozapine treatment  
  Michal Taler, Petach-Tikva, Israel Speaker
005 Cardiotoxicity associated with clozapine; a potent hypothesis of immunomodulation by clozapine: a case report  
  Emmanouil Rizos, Athens - Haidari, Greece Speaker
006 A randomised, double-blind, placebo-controlled study to assess cardiac effects of single-dose BI 409306 in healthy male volunteers  
  Claudia VŲlk, Ingelheim am Rhein, Germany Speaker
007 Prevention of relapse in schizophrenia: a phase II study evaluating efficacy, safety, and tolerability of oral BI 409306  
  Michael Sand, Ridgefield, USA Speaker
008 The influence of 3 weeks of antipsychotic treatment on cell adhesion molecules in drug naive patients with schizophrenia spectrum disorder  
  Farivar Fathian, Bergen, Norway Speaker
009 First episode of schizophrenia under antipsychotic treatment is followed by recovery of monoamine oxidase activity but not the degree of endogenous intoxication  
  Marat Uzbekov, Moscow, Russia Speaker
010 Psychopathology and differentiated psychopharmacological treatment strategy in subtypes of 22q11.2 deletion syndrome  
  Willem M. A. Verhoeven, Venray, Netherlands Speaker
011 New 1,5-benzodiazepin-2-ones with anticonvulsant and tranquilizer activity  
  Vitalii Palchykov, Dnipro, Ukraine Speaker
012 Pitfalls of managing schizophrenia  
  Mohammed Farik Jabir, Singapore, Singapore Speaker
No. P-03 - Poster Session
Time: 13.30-14.30
Room: Event Area, Ground Floor
Session title: Outcome and stigma
  Armida Mucci, Naples, Italy Chairperson
001 Predictors of remission in late-life schizophrenia: a 5-year follow-up study in a Dutch psychiatric catchment area  
  Sjors Lange, Amsterdam, Netherlands Speaker
002 Predictors of remission in the acute treatment of first-episode schizophrenia involuntarily hospitalized and treated with an algorithm-based pharmacotherapy: secondary analysis of an observational study  
  Bunta Yoshimura, Miyakojima, Japan Speaker
003 The time-course of negative symptoms and their relationships with social functioning and quality of life of first episode schizophrenia patients: a prospective 11 - 15 year follow - study  
  Katarzyna GolÍbiewska, PoznaŮ, Poland Speaker
004 A description of physical health outcomes in a first episode psychosis xohort over 20 years  
  Donal OīKeeffe, Dublin, Ireland Speaker
005 The financial crisis in Greece and the impact on psychiatric patients  
  Markella Fiste, Chaidari Athens, Greece Speaker
006 Burden of disease for caregivers of individuals with schizophrenia  
  Mihail Cristian Pirlog, Bucharest, Romania Speaker
007 Psychosocial functioning of families and anti-relapse behaviour in schizophrenia  
  Elena Gutkevich, Tomsk, Russia Speaker
008 Stigma experiences in first-episode patients with schizophrenia: do they erode self-esteem in the long-term?  
  Harald Zšske, DŁsseldorf, Germany Speaker
009 Effects of psychological skills training on family stigma in schizophrenia  
  Farshid Shamsaei, Hamedan, Islamic Republic of Iran Speaker
010 Impact and differences of perceived course of illness on desire for social distance towards people suffering from schizophrenia or depression in Hanoi, Vietnam  
  Lara Kim Martensen, Berlin, Germany Speaker
011 An ongoing trial for recovery-oriented and co-productive reform of academic schizophrenia research society: a challenge of the Japanese Society of Schizophrenia Research  
  Masato Fukuda, Maebashi, Gunma, Japan Speaker
No. P-04 - Poster Session
Time: 13.30-14.30
Room: Event Area, Ground Floor
Session title: Neuropsychology
  Daniel Freeman, Oxford, United Kingdom Chairperson
001 Cognitive dysfunctions in schizophrenia and bipolar disorder in Chilean patients  
  Aida Ruiz, Santiago, Chile Speaker
002 Proverb comprehension deficits in patients suffering from schizophrenia spectrum disorders - neurocognitive and social cognitive correlates  
  Daniela Roesch Ely, Heidelberg, Germany Speaker
003 Semantic fluency as a compensatory mechanism indicator in healthy subjects with high genetic loading for schizophrenia  
  Sung Nyun Kim, Seoul, Republic of Korea Speaker
004 Language lateralization and attention impairment in young adults with ultra-high risk for psychosis: a dichotic listening study  
  Ingvild Aase, Stavanger, Norway Speaker
005 Individuals with subclinical persecutory delusions show impaired adaptation after being exposed to a volatile environment  
  Katharina Wellstein, Zurich, Switzerland Speaker
006 Neurocognition and psychotic symptoms in patients with first-episode psychosis: a preliminary study  
  Regina Vila-Badia, Sant Boi de Llobregat, Spain Speaker
007 Do cognitive deficits in early-onset of schizophrenia are more severe than in adulthood-onset schizophrenia after many years of psychosis?  
  Beata Hintze, Warsaw, Poland Speaker
008 The effect of cueing on bottom-up biases during working memory encoding in schizophrenia  
  Catherine Barnes, Frankfurt am Main, Germany Speaker
009 Cognitive characteristics of homicide offenders with schizophrenia  
  Katharina Nymo Engelstad, Drammen, Norway Speaker
No. S-05 - Symposium
Time: 14.30-16.00
Room: Harvard
Session title: Migration and psychosis
  Jean-Paul Selten, Leiden, Netherlands Chairperson
  Andreas Meyer-Lindenberg, Mannheim, Germany Co-Chairperson
No. S-06 - Symposium
Time: 14.30-16.00
Room: Stanford
Session title: Focus on recovery-limiting psychopathological dimensions in schizophrenia: electrophysiological and brain imaging correlates of negative symptoms and disorganization
  Armida Mucci, Naples, Italy Chairperson
  Thomas Koenig, Bern, Switzerland Co-Chairperson
No. O-01 - Oral Presentation
Time: 14.30-16.00
Room: Princeton
Session title: Factors impacting the risk of developing psychosis
  Ingrid Melle, Oslo, Norway Chairperson
No. SA-01 - State-of-the-Art-Lecture
Time: 14.30-16.00
Room: Plenary
Session title: State-of-the-Art Lectures 1
  Robin M. Murray, London, United Kingdom Chairperson
001 Conceptualizing schizophrenia from the beginning - an epidemiological perspective  
  Wulf RŲssler, Zurich, Switzerland Speaker
002 Brain-imaging in psychosis  
  Eva Meisenzahl, DŁsseldorf, Germany Speaker
  Discussion (15 min)
No. D-01 - Pro and Con Debate
Time: 16.30-18.00
Room: Plenary
Session title: Cannabis: causal or not?
  Andrť Aleman, Groningen, Netherlands Chairperson
001 Pro: Cannabis: causal or not?  
  Robin M. Murray, London, United Kingdom Pro-Author
002 Con: Cannabis: causal or not?  
  John MacLeod, Bristol, United Kingdom Con-Author
  Discussion (15 min)
No. S-07 - Symposium
Time: 16.30-18.00
Room: Harvard
Session title: Optimizing the path to recovery in treatment-resistant and difficult-to treat schizophrenia: challenges and alternatives
  Matti Isohanni, Oulu, Finland Chairperson
  Eva M. Grasa, Barcelona, Spain Co-Chairperson
No. S-08 - Symposium
Time: 16.30-18.00
Room: Stanford
Session title: Biological diagnostic markers for schizophrenia
  Carsten Korth, DŁsseldorf, Germany Chairperson
  Oliver Howes, London, United Kingdom Co-Chairperson
No. O-02 - Oral Presentation
Time: 16.30-18.00
Room: Princeton
Session title: Psychopathology and comorbidity
  Bernard Sabbe, Duffel, Belgium Chairperson
  Discussion (15 min)